Paper31574418
Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC).
Rivin Del Campo E and 16 others. Eur J Cancer, 2019. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC). Papers, record 31574418. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31574418
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC).
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anus Neoplasms | Major topic |
| Chemoradiotherapy | Major topic |
| Clinical Trials, Phase II as Topic | Major topic |
| Clinical Trials, Phase III as Topic | Major topic |
| Fluorouracil | Major topic |
| Mitomycin | Major topic |
| Combined Modality Therapy | |
| Humans | |
| Neoplasm Recurrence, Local | |
| Radiotherapy Dosage | |
| Treatment Outcome |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U10 CA180820 | NCI NIH HHS | United States | U10CA180820 | PubMed and NIH | NIH RePORTER |
| U10 CA180822 | NCI NIH HHS | United States | U10CA180822 | PubMed and NIH | NIH RePORTER |
| U10 CA180868 | NCI NIH HHS | United States | U10CA180868 | PubMed and NIH | NIH RePORTER |
| UG1 CA233270 | NCI NIH HHS | United States | UG1CA233270 | PubMed and NIH | NIH RePORTER |
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30128811 | Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy. | Med Oncol | 2018 | https://conductscience.org/library/papers/30128811 | PubMed |
| 2 | 22529257 | Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/22529257 | PubMed |
| 3 | 30773194 | Intensity-modulated radiation therapy of anal squamous cell carcinoma: Relationship between delineation quality and regional recurrence. | Radiother Oncol | 2019 | https://conductscience.org/library/papers/30773194 | PubMed |
| 4 | 30172453 | Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: A pooled analysis of two prospective trials (KANAL 2 and ACCORD 03). | Radiother Oncol | 2018 | https://conductscience.org/library/papers/30172453 | PubMed |
| 5 | 29755663 | The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy. | Oncotarget | 2018 | https://conductscience.org/library/papers/29755663 | PubMed |
| 6 | 24721444 | Chemoradiotherapy for squamous cell cancer of the anal canal: a systematic review. | Clin Oncol (R Coll Radiol) | 2014 | https://conductscience.org/library/papers/24721444 | PubMed |
| 7 | 20368838 | Radical radiotherapy for locally advanced cancer of uterine cervix. | Cancer Res Treat | 2004 | https://conductscience.org/library/papers/20368838 | PubMed |
| 8 | 12873670 | Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. | Int J Radiat Oncol Biol Phys | 2003 | https://conductscience.org/library/papers/12873670 | PubMed |
| 9 | 25239441 | Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. | Eur J Surg Oncol | 2014 | https://conductscience.org/library/papers/25239441 | PubMed |
| 10 | 8934049 | A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. | Clin Oncol (R Coll Radiol) | 1996 | https://conductscience.org/library/papers/8934049 | PubMed |
| 11 | 34400269 | Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer. | Int J Radiat Oncol Biol Phys | 2022 | https://conductscience.org/library/papers/34400269 | PubMed |
| 12 | 20354531 | Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). | Br J Cancer | 2010 | https://conductscience.org/library/papers/20354531 | PubMed |
| 13 | 26995081 | Treatment that follows guidelines closely dramatically improves overall survival of patients with anal canal and margin cancers. | Crit Rev Oncol Hematol | 2016 | https://conductscience.org/library/papers/26995081 | PubMed |
| 14 | 21450408 | Chemotherapy/chemoradiation in anal cancer: a systematic review. | Cancer Treat Rev | 2011 | https://conductscience.org/library/papers/21450408 | PubMed |
| 15 | 12837978 | Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy. | Oncology | 2003 | https://conductscience.org/library/papers/12837978 | PubMed |
| 16 | 31167658 | MR-guidance in clinical reality: current treatment challenges and future perspectives. | Radiat Oncol | 2019 | https://conductscience.org/library/papers/31167658 | PubMed |
| 17 | 30201015 | Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study. | Radiat Oncol | 2018 | https://conductscience.org/library/papers/30201015 | PubMed |
| 18 | 29527660 | Impact of socioeconomic status on survival for patients with anal cancer. | Cancer | 2018 | https://conductscience.org/library/papers/29527660 | PubMed |
| 19 | 9069302 | Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications. | Int J Radiat Oncol Biol Phys | 1997 | https://conductscience.org/library/papers/9069302 | PubMed |
| 20 | 24401669 | Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study. | Am J Clin Oncol | 2016 | https://conductscience.org/library/papers/24401669 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42583088 | Biological features of squamous cell carcinoma of the anus-a deep dive review. | ESMO Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/42583088 | PubMed |
| 42471955 | Simultaneous integrated boost vs sequential boost chemoradiotherapy in anal squamous cell carcinoma: Association with improved disease-free survival and the role of treatment delivery parameters. | Clin Transl Radiat Oncol | 2026 | https://conductscience.org/library/papers/42471955 | PubMed |
| 41588386 | Long-term outcomes and anorectal functional status of patients with anal squamous cell carcinoma treated with the modern technique of intensity-modulated radiotherapy. | BMC Cancer | 2026 | https://conductscience.org/library/papers/41588386 | PubMed |
| 37632562 | A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers. | Eur J Nucl Med Mol Imaging | 2023 | https://conductscience.org/library/papers/37632562 | PubMed |
| 35402741 | Acceptance of physical activity monitoring in cancer patients during radiotherapy, the GIROfit phase 2 pilot trial. | Tech Innov Patient Support Radiat Oncol | 2022 | https://conductscience.org/library/papers/35402741 | PubMed |
| 33430396 | MRI-Based Radiomics Input for Prediction of 2-Year Disease Recurrence in Anal Squamous Cell Carcinoma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33430396 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TRAF3IP2 | 10758 | PubTator's text mining | https://conductscience.org/library/genes/10758 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31574418
GET https://conductscience.org/api/papers/v1/31574418/references?page=2